Ultrasound engine heads for RSNA show
Analogic will introduce its AN2300 Digital Ultrasound Engine on the RSNA exhibit floor. The company’s digital engine provides the hardware and real-time software necessary to acquire, process, and convert ultrasound echo information into a video
Analogic will introduce its AN2300 Digital Ultrasound Engine on the RSNA exhibit floor. The company’s digital engine provides the hardware and real-time software necessary to acquire, process, and convert ultrasound echo information into a video display. It can support clinical applications in cardiology, general radiology, breast, and small parts imaging. This PC-based subsystem, designed for sale to OEMs, is intended to cost-effectively address the imaging needs of specific applications or even niche markets that otherwise might not justify the development of an imaging platform. A complete turnkey system can be created quickly by adding transducers, a unique user interface, ergonomic packaging, clinical software application, and a display. AN2300’s linear waveform transmit and receive beamformers use Analogic’s second-generation ASIC and broadband spline interpolation filter, capable of synthesizing up to 256 receive channels. Advanced imaging modes include parallel beam processing, harmonic receive of up to 15 MHz, beam steering, spectral Doppler, color-flow or power modes, and line-interleaved duplex or triplex combination modes. Complementing the engine is an open software interface that allows developers to program the system using a high-level programming language under Windows NT. An in-depth knowledge of the detailed engine hardware is not required.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
